Question 1
How many patients have been diagnosed over the last 6 months with epithelial ovarian, fallopian tube or primary peritoneal cancer?
If none, do you refer ovarian cancer patients to another trust, if so which one?
Question 2
Of the ovarian patients, how many have been tested for BRCA mutation?
If unknown please state unknown and move to Question 4
Question 3
Of the ovarian patient BRCA mutation tests how many tested positive?
Question 4
Of the ovarian patients diagnosed over the last 6 months, how many have been treated with the below:
Paclitaxel in combination with a platinum-based compound
Platinum-based therapy alone (cisplatin or carboplatin)
Bevacizumab in combination with paclitaxel and carboplatin
Olaparib
Niraparib
Rucaparib
Pegylated liposomal doxorubicin hydrochloride (PLDH) as monotherapy or in combination with a platinum-based compound
Question 5
Of those who were positive for a BRCA mutation, how many received Olaparib for 1st line maintenance?
Question 6
Of those who were positive for a BRCA mutation, how many received Bevacizumab in combination with paclitaxel and carboplatin for 1st line maintenance?

Download response Ovarian Cancer. 200320